What is Calcitonin (Miacalcin)?

Calcitonin is a hormone that your body naturally produces in the thyroid gland, and it plays a key role in keeping calcium levels balanced and bones healthy. The version used medically is usually derived from salmon, because salmon calcitonin is about 40 times more potent in humans than the human version. It is available as a nasal spray (Miacalcin, Fortical) or as an injection, and has been used clinically for decades in bone health management.

How does Calcitonin (Miacalcin) work?

Calcitonin works mainly by putting the brakes on osteoclasts — the cells responsible for breaking down bone tissue. By slowing bone breakdown, it helps preserve bone density and can ease the deep aching pain that often comes with conditions like osteoporosis or Paget's disease. It also tells the kidneys to release more calcium into the urine rather than letting excess calcium build up in the blood, which is helpful during a hypercalcemic crisis.

What forms does Calcitonin (Miacalcin) come in?

The nasal spray (200 IU per actuation) is the most common form for long-term osteoporosis management and is self-administered daily, alternating nostrils. The injectable form (100 IU/mL) is typically reserved for acute hypercalcemia or Paget's disease and is administered by a healthcare provider. Oral formulations are under investigation but not yet widely available.

Where it comes from:

Calcitonin was first isolated in the 1960s and the salmon-derived form was approved by the FDA in the 1980s for osteoporosis and Paget's disease. It was among the first hormone-based therapies for bone loss before bisphosphonates became widely available. Its pain-relieving properties, particularly for vertebral fractures, have made it a useful option in certain clinical scenarios even as newer bone therapies have emerged.

What does Calcitonin (Miacalcin) help with?

• Osteoporosis: Calcitonin slows the activity of bone-dissolving cells, helping maintain bone density over time. Studies have shown modest improvements in spinal bone density with long-term nasal spray use, and it is particularly valued for women who cannot tolerate other osteoporosis medications.
• Bone pain (vertebral fractures): One of calcitonin's most appreciated benefits is its ability to ease the sharp, deep pain that follows a vertebral compression fracture — the kind that happens when osteoporotic bones collapse under pressure. It appears to work through pain-modulating pathways in the brain and spinal cord, independent of its bone effects, offering relief within days for many people.
• High calcium levels (hypercalcemia): When blood calcium spikes dangerously — often due to cancer or overactive parathyroid glands — injectable calcitonin can bring levels down quickly by signaling the kidneys to excrete more calcium and slowing bone calcium release. It acts faster than most other treatments, making it useful in the acute setting.
• Paget's disease of bone: Paget's disease causes chaotic, accelerated bone remodeling that leads to pain, deformity, and fracture risk. Calcitonin quiets this overactive bone turnover, reducing pain and helping normalize bone structure. While bisphosphonates are now first-line, calcitonin remains an option for those who cannot use them.
• Postmenopausal bone loss: After menopause, falling estrogen levels speed up bone breakdown. Calcitonin directly slows this process and has been approved for postmenopausal osteoporosis for decades. It is especially considered for women who are at least 5 years past menopause.
• Bone loss from spinal cord injury: People who become immobilized after spinal cord injury lose bone rapidly in the legs and pelvis. Early calcitonin treatment has been studied as a way to slow this bone loss in the weeks and months following injury, with some evidence of benefit in preserving bone density.
• Bone pain from cancer metastasis: When cancer spreads to bones, it causes severe pain by triggering aggressive bone breakdown. Calcitonin can reduce both the bone destruction and the associated pain, sometimes used alongside other treatments to improve quality of life.
• Immobilization-related bone loss: Extended bed rest or immobility accelerates bone loss as the skeleton adapts to reduced load. Calcitonin has been used to slow this process, particularly in post-surgical or post-injury patients who are temporarily non-weight-bearing.

What can Calcitonin (Miacalcin) help prevent?

• Vertebral fractures in postmenopausal osteoporosis (modest evidence from the PROOF trial)
• Acute bone loss following spinal cord injury or immobilization

Which foods are rich in Calcitonin (Miacalcin)?

Calcitonin is a hormone — it cannot be obtained from food and is only available as a prescription medication. However, supporting the same bone-health pathway through diet is very practical. Calcium-rich foods like dairy (yogurt, milk, cheese), fortified plant milks, sardines with bones, kale, and broccoli give the skeleton the raw material it needs. Vitamin D from fatty fish (salmon, mackerel), egg yolks, and fortified foods helps the body absorb that calcium efficiently. Magnesium-rich foods like pumpkin seeds, almonds, and dark leafy greens support bone mineralization alongside calcitonin's effects. Limiting alcohol and high-sodium processed foods also reduces calcium losses through the kidneys.

What are the side effects of Calcitonin (Miacalcin)?

• Nasal irritation, runny nose, or nosebleeds (nasal spray)
• Flushing or warmth in the face, ears, or hands (more common with injection)
• Nausea or mild stomach upset (usually passes with continued use)
• Headache
• Dizziness
• Low calcium symptoms: muscle cramps, tingling in hands or feet (rare)
• Injection site redness or swelling
• Allergic reaction (rare; skin test recommended before first injection use)
• Possible small increased cancer risk with very long-term use (flagged by FDA in 2012 — discuss with your doctor for use beyond 5 years)

Good to know:

Calcitonin nasal spray is generally well tolerated for most people with only mild local effects. The injectable form tends to cause more noticeable side effects. Serious reactions are uncommon but can include low blood calcium or rare allergic responses.

How much Calcitonin (Miacalcin) should you take?

• Recommended daily: Osteoporosis (nasal spray): 200 IU once daily, alternating nostrils each day. Paget's disease or hypercalcemia (injection): 50–100 IU per day or every other day, as directed by a physician. Doses are always set by a prescribing doctor.
• Best time of day: Nasal spray is typically used at the same time each day — evening use may slightly favor bone remodeling cycles, but consistency matters more than timing.
• With or without food: The nasal spray can be used with or without food. Injectable forms are generally given independently of meals. Always take adequate calcium and vitamin D alongside calcitonin therapy.
• Time to effect: Pain relief for vertebral fractures: often within 1–2 weeks. Bone density improvements: 6–12 months of consistent use.
• How long to take it: Use is typically long-term for osteoporosis management, reviewed periodically by your doctor. Given the 2012 FDA signal about potential cancer risk with very prolonged use, most clinicians reassess the benefit-risk balance after 5 years of continuous therapy.